Home/Filings/4/0001493152-23-035712
4//SEC Filing

Bernards Rene 4

Accession 0001493152-23-035712

CIK 0001335105other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 6:10 PM ET

Size

6.4 KB

Accession

0001493152-23-035712

Insider Transaction Report

Form 4
Period: 2023-10-02
Transactions
  • Purchase

    Common Stock

    2023-10-03$2.51/sh+5,527$13,873
  • Purchase

    Common Stock

    2023-10-02$2.29/sh+4,473$10,243
Footnotes (2)
  • [F1]The Reporting Person acquired an aggregate of 4,473 shares in numerous trades at prices ranging from $2.29-$2.40
  • [F2]The Reporting Person acquired an aggregate of 5,527 shares in numerous trades ranging from $2.51-$2.58

Documents

1 file

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

Entity typeother

Related Parties

1
  • filerCIK 0001939159

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:10 PM ET
Size
6.4 KB